The Wall Street Journal reported that at least six companies' disclosures that they had received subpoenas were related to the investigation, and subpoenas for additional companies are expected in the coming months.
Shares of the company fell 40 percent Thursday following a story late Wednesday afternoon by Bloomberg, which reported that a bankruptcy filing was a potential option.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Humana alleges that Mallinckrodt illegally jacked up the price of the injected drug Acthar, causing the insurance company to pay several times more for the drug - which the FDA approved in 1952 - than it otherwise would have.
Study published in JAMA indicates nearly 90 percent of doctors prescribing HP Acthar Gel took payments from drug's manufacturer.
A dozen Republican committee heads and ranking Democrats on health-related panels collected $281,600 from pharma-related PACs in the first quarter, up 80 percent from what people in the same positions collected in the first quarter of 2015, the data show.
Also, Astellas and GE Healthcare make big buys, interesting insight on ResearchKit and AZ's lupus treatment gets a boost.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.